News & Insights

pexels-nappy
pexels-nappy
pexels-nappy
pexels-nappy
pexels-nappy
pexels-nappy
pexels-nappy
pexels-nappy
pexels-nappy

GCT-007 CONTINUES TO RECEIVE EXCEPTIONAL GLIOBLASTOMA PRE-CLINICAL RESULTS

For Immediate Release Contact: info@globalcancertechnology.com GCT-007 CONTINUES TO RECEIVE EXCEPTIONAL

pexels-nappy

CHINA ISSUES GLOBAL CANCER TECHNOLOGY PATENT FOR GCT-007

For Immediate Release  Contact: info@globalcancertechnology.com CHINA ISSUES GLOBAL CANCER TECHNOLOGY

pexels-nappy

DATA SHOWS GCT-007 TO BE COMPARABLE TO PAXALISIB IN INITIAL PRE-CLINICAL STUDIES

For Immediate Release Contact: info@globalcancertechnology.com                                                                                                 GLOBAL CANCER TECHNOLOGY REPORTS

12/42